Vaxcyte Inc (5VA)

Currency in EUR
30.80
-0.20(-0.65%)
Delayed Data·
5VA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
30.8030.80
52 wk Range
25.00108.00
Key Statistics
Bid/Ask
30.00 / 30.40
Prev. Close
31
Open
30.8
Day's Range
30.8-30.8
52 wk Range
25-108
Volume
10
Average Volume (3m)
311
1-Year Change
-60.76%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
5VA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Vaxcyte Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Vaxcyte Inc Company Profile

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; and VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.

Compare 5VA to Peers and Sector

Metrics to compare
5VA
Peers
Sector
Relationship
P/E Ratio
0.0x−4.6x−0.5x
PEG Ratio
0.000.020.00
Price/Book
0.0x3.6x2.6x
Price / LTM Sales
0.0x9.4x3.2x
Upside (Analyst Target)
0.0%187.2%41.2%
Fair Value Upside
Unlock10.9%6.2%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

5VA Income Statement

People Also Watch

17.28
SRPT
+24.70%
37.32
SRRK
+0.62%
3.69
REPL
+16.25%
36.80
RVMD
-1.25%
36.38
CYTK
-0.70%

FAQ

What Stock Exchange Does Vaxcyte Inc Trade On?

Vaxcyte Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Vaxcyte Inc?

The stock symbol for Vaxcyte Inc is "5VA."

What Is the Vaxcyte Inc Market Cap?

As of today, Vaxcyte Inc market cap is 3.89B.

What Is Vaxcyte Inc's Earnings Per Share (TTM)?

The Vaxcyte Inc EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 5VA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Vaxcyte Inc Stock Split?

Vaxcyte Inc has split 0 times.

What is the current trading status of Vaxcyte Inc (5VA)?

As of 29 Jul 2025, Vaxcyte Inc (5VA) is trading at a price of 30.80, with a previous close of 31.00. The stock has fluctuated within a day range of 30.80 to 30.80, while its 52-week range spans from 25.00 to 108.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.